kabutan

TAUNS Laboratories,Inc.(197A) Summary

197A
TSE Standard
TAUNS Laboratories,Inc.
526
JPY
0
(0.00%)
Jan 29, 3:30 pm JST
3.43
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
526.9
Jan 29, 3:24 pm JST
Summary Chart Historical News Financial Result
PER
6.5
PBR
3.61
Yield
5.32%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
526 JPY 3.43 USD
Previous Close Jan 28
526 JPY 3.44 USD
High Jan 29, 3:12 pm
529 JPY 3.45 USD
Low Jan 29, 9:01 am
521 JPY 3.40 USD
Volume
327,400
Trading Value
0.17B JPY 1.12M USD
VWAP
525.59 JPY 3.44 USD
Minimum Trading Value
52,600 JPY 343 USD
Market Cap
0.06T JPY 0.37B USD
Number of Trades
349
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly High
1-Year Average
609
1-Year High Feb 14, 2025
2,547
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 120,300 2,519,500 20.94
Jan 16, 2026 106,800 2,799,000 26.21
Jan 9, 2026 115,200 2,923,300 25.38
Dec 26, 2025 186,000 2,871,600 15.44
Dec 19, 2025 108,900 2,875,700 26.41
Company Profile
TAUNS Laboratories, Inc. specializes in the development and manufacture of in vitro diagnostic medical devices and research reagents.
Sector
Pharmaceuticals
TAUNS Laboratories, Inc. focuses on the development and manufacture of in vitro diagnostic medical devices and research reagents as its core business, primarily offering antigen test kits for infectious disease clinical testing. By utilizing the immunochromatographic method, the company enables rapid diagnosis without the need for specialized equipment. Key features of their products include the common use of specimen extraction solution and high visibility black lines achieved through their proprietary "platinum-gold colloid" nanotechnology. The company provides its products to domestic and international medical institutions, international organizations, research institutes, and biotech ventures. Their main product line includes test kits for influenza, novel coronavirus, adenovirus, and RSV, among others.